Electrocompetent Cells Market Report 2026

Electrocompetent Cells Market Overview

• Electrocompetent Cells market size has reached to $1.57 billion in 2025 • Expected to grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: The Rising Demand For Genetic Engineering Is Fueling The Growth Of The Market Due To Increasing Agricultural Productivity And Genetic Modifications Across Sectors • Market Trend: Automated Cell Processing Software Solutions Enhancing Manufacturing Efficiency And cGMP Compliance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electrocompetent Cells Market?

Electrocompetent cells are bacterial cells that have been specially treated to improve their ability to take up foreign deoxyribonucleic acid (DNA) via electroporation. Their membranes are made permeable through a washing process with a cold, ion-free solution, often containing glycerol or water. When subjected to a short electric pulse, the membrane pores open, allowing plasmid DNA to enter. These cells are commonly used when high transformation efficiency is essential in genetic engineering. The main product types of electrocompetent cells are bacterial electrocompetent cells, yeast electrocompetent cells, plant electrocompetent cells, and mammalian electrocompetent cells. Bacterial electrocompetent cells are engineered to have permeable membranes, allowing for highly efficient DNA uptake during electroporation. It utilizes various technologies such as electroporation technology, chemical transformation technology, and others, with several packaging formats, including tubes, plates, and custom formats. It is applicable in various applications such as gene cloning, protein expression, transfection studies, gene editing, therapeutic applications, and others, and is used by several end-users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and others.

What Is The Electrocompetent Cells Market Growth Forecast?

The electrocompetent cells market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to growth of gene therapy research, rising crispr-based studies, expansion of biotechnology pipelines, increased outsourcing to cros, demand for high-throughput genetic engineering. Major trends in the forecast period include rising demand for high-efficiency transformation cells, growing use in gene editing applications, increasing adoption in synthetic biology research, expansion of custom and ready-to-use cell formats, rising utilization in therapeutic development.

Global Electrocompetent Cells Market Segmentation

1) By Product Type: Bacterial Electrocompetent Cells, Yeast Electrocompetent Cells, Plant Electrocompetent Cells, Mammalian Electrocompetent Cells 2) By Technology: Electroporation Technology, Chemical Transformation Technology, Other Technologies 3) By Packaging Format: Tubes, Plates, Custom Formats 4) By Application: Gene Cloning, Protein Expression, Transfection Studies, Gene Editing, Therapeutic Applications, Other Applications 5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Other End-Users Subsegments: 1) By Bacterial Electrocompetent Cells: E. coli Electrocompetent Cells, Salmonella Electrocompetent Cells, Clostridium Electrocompetent Cells, Bacillus Electrocompetent Cells 2) By Yeast Electrocompetent Cells: Saccharomyces Cerevisiae Electrocompetent Cells, Pichia Pastoris Electrocompetent Cells, Schizosaccharomyces Pombe Electrocompetent Cells 3) By Plant Electrocompetent Cells: Arabidopsis Thaliana Electrocompetent Cells, Nicotiana Benthamiana Electrocompetent Cells, Maize Electrocompetent Cells 4) By Mammalian Electrocompetent Cells: HEK293 Electrocompetent Cells, Chinese Hamster Ovary (CHO) Electrocompetent Cells, NIH 3T3 Electrocompetent Cells

What Is The Driver Of The Electrocompetent Cells Market?

The rising demand for genetic engineering is expected to propel the growth of the electrocompetent cells market going forward. Genetic engineering involves intentionally changing an organism's genetic material to modify its traits or behavior. The rise in genetic engineering is driven by the need for higher agricultural productivity, allowing the creation of crops with increased yields and pest resistance, minimizing chemical reliance. The growing need for genetic engineering fuels the demand for electrocompetent cells, which are crucial for efficient DNA transformation. As genetic modifications expand across research, healthcare, and agriculture, the need for premium electrocompetent cells is rising. For instance, in April 2025, according to the Economic Research Service, a US-based government agency, in 2024, genetically engineered, insect-resistant seeds were used on 90 percent of cotton acres in the U.S. Therefore, the rising demand for genetic engineering is driving the growth of the electrocompetent cells industry.

Key Players In The Global Electrocompetent Cells Market

Major companies operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Biosciences, Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs, OriGene Technologies, MaxCyte, LGC Biosearch Technologies, IBA GmbH, Zymo Research, Creative Biolabs, Inovio Pharmaceuticals Inc., Canvax, Yeastern Biotech, ZellBio GmbH, Scarab Genomics LLC, Intact Genomics.

Global Electrocompetent Cells Market Trends and Insights

Major companies operating in the electrocompetent cells market are focusing on developing advanced solutions, such as automated cell processing technology, to improve scalability in genetic engineering workflows. Automated cell processing technology involves software-driven systems that manage the handling, cultivation, modification, and preservation of cells with minimal manual input. This approach improves operational efficiency, standardization, and scalability in areas such as cell therapy, regenerative medicine, and biomanufacturing. For instance, in 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Gibco Cell Therapy Systems (CTS) Cellmation Software, a validated automation solution designed to connect and integrate workflows across multiple cell therapy instruments while enabling cGMP compliance. This software connects core instruments including the CTS DynaCellect Magnetic Separation System, CTS Rotea Counterflow Centrifugation System, CTS Xenon Electroporation System, Heracell Vios CR CO2 Incubator, and Cryomed Controlled-Rate Freezer within a single user-friendly interface, reducing manual touchpoints from an estimated 40 in traditional processes, thereby minimizing error and contamination risks while ensuring traceability, repeatability, and 21 CFR Part 11 compliance for scaling cGMP manufacturing processes.

What Are Latest Mergers And Acquisitions In The Electrocompetent Cells Market?

In January 2024, MaxCyte Inc., a US-based provider of electroporation systems, partnered with Wugen Inc. to advance innovative cancer therapies with scalable cell engineering technology. The partnership aims to expedite the scale-up of clinical and commercial manufacturing of Wugen’s allogeneic, off-the-shelf cell therapies targeting hematologic and solid tumor cancers, leveraging MaxCyte’s scalable and high-efficiency cell engineering technology to advance these therapies to patients with limited treatment options. Wugen Inc. is a US-based company that develops off-the-shelf cellular therapies for cancer.

Regional Insights

North America was the largest region in the electrocompetent cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Electrocompetent Cells Market?

The electrocompetent cells market consists of revenues earned by entities by providing services such as custom strain development, plasmid DNA amplification, library construction, and technical support for molecular biology applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocompetent cells market includes sales of insect electrocompetent cells, fungal electrocompetent cells, and algal electrocompetent cells. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Electrocompetent Cells Market Report 2026?

The electrocompetent cells market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the electrocompetent cells industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.